Hugging Face's logo

Datasets:
Ichlibitiche
/
csa-clinical-stage-asset-intelligence-sample

Tasks:
Tabular Classification
Modalities:
Text
Formats:
csv
Size:
< 1K
Tags:
biotech
clinical-trials
finance
pharmaceuticals
catalyst-calendar
healthcare
Libraries:
Datasets
pandas
Polars
License:
Dataset card Data Studio Files
xet
 Community
csa-clinical-stage-asset-intelligence-sample
File size: 20,330 Bytes
2f942cf
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
event_date,ticker,asset,event_type,event_window,date_precision,confidence,source,nct_id,source_url
2026-07-18,BMY,mezigdomide,READOUT,"Jul 18, 2026",day,medium,clinicaltrials,NCT05552976,https://clinicaltrials.gov/study/NCT05552976
2026-07-25,BMY,deucravacitinib,READOUT,"Jul 25, 2026",day,medium,clinicaltrials,NCT04036435,https://clinicaltrials.gov/study/NCT04036435
2026-07-27,REGN,fianlimab,READOUT,"Jul 27, 2026",day,medium,clinicaltrials,NCT05608291,https://clinicaltrials.gov/study/NCT05608291
2026-07-31,HRMY,pitolisant,READOUT,Jul 2026,month,medium,clinicaltrials,NCT06366464,https://clinicaltrials.gov/study/NCT06366464
2026-07-31,LXRX,sotagliflozin,READOUT,Jul 2026,month,medium,clinicaltrials,NCT06481891,https://clinicaltrials.gov/study/NCT06481891
2026-07-31,JAZZ,zanidatamab,READOUT,"Jul 31, 2026",day,medium,clinicaltrials,NCT05152147,https://clinicaltrials.gov/study/NCT05152147
2026-08-01,MRK,tulisokibart,READOUT,"Aug 1, 2026",day,medium,clinicaltrials,NCT06052059,https://clinicaltrials.gov/study/NCT06052059
2026-08-24,AZN,camizestrant,READOUT,"Aug 24, 2026",day,medium,clinicaltrials,NCT04711252,https://clinicaltrials.gov/study/NCT04711252
2026-08-30,PFE,elranatamab,READOUT,"Aug 30, 2026",day,medium,clinicaltrials,NCT06152575,https://clinicaltrials.gov/study/NCT06152575
2026-08-31,PHVS,deucrictibant,READOUT,Aug 2026,month,medium,clinicaltrials,NCT06669754,https://clinicaltrials.gov/study/NCT06669754
2026-08-31,SBFM,lerotinib,READOUT,Aug 2026,month,medium,clinicaltrials,NCT04415853,https://clinicaltrials.gov/study/NCT04415853
2026-08-31,SLGL,patidegib,READOUT,Aug 2026,month,medium,clinicaltrials,NCT06050122,https://clinicaltrials.gov/study/NCT06050122
2026-08-31,LLY,retatrutide,READOUT,Aug 2026,month,medium,clinicaltrials,NCT06260722,https://clinicaltrials.gov/study/NCT06260722
2026-09-01,INCY,tafasitamab,READOUT,"Sep 1, 2026",day,medium,clinicaltrials,NCT04824092,https://clinicaltrials.gov/study/NCT04824092
2026-09-27,BIIB,litifilimab,READOUT,"Sep 27, 2026",day,medium,clinicaltrials,NCT04961567,https://clinicaltrials.gov/study/NCT04961567
2026-09-28,MLTX,sonelokimab,READOUT,"Sep 28, 2026",day,medium,clinicaltrials,NCT06768671,https://clinicaltrials.gov/study/NCT06768671
2026-09-30,AZN,datopotamab deruxtecan,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT06417814,https://clinicaltrials.gov/study/NCT06417814
2026-09-30,KURA,daunorubicin,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT03117751,https://clinicaltrials.gov/study/NCT03117751
2026-09-30,DAN,erwinia asparaginase,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT03117751,https://clinicaltrials.gov/study/NCT03117751
2026-09-30,BIIB,litifilimab,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT04895241,https://clinicaltrials.gov/study/NCT04895241
2026-09-30,DAN,mercaptopurine,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT03117751,https://clinicaltrials.gov/study/NCT03117751
2026-09-30,AZN,monalizumab,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT05221840,https://clinicaltrials.gov/study/NCT05221840
2026-09-30,DAN,nelarabine,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT03117751,https://clinicaltrials.gov/study/NCT03117751
2026-09-30,AZN,oleclumab,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT05221840,https://clinicaltrials.gov/study/NCT05221840
2026-09-30,DAN,pegaspargase,READOUT,"Sep 30, 2026",day,medium,clinicaltrials,NCT03117751,https://clinicaltrials.gov/study/NCT03117751
2026-10-19,BMY,deucravacitinib,READOUT,"Oct 19, 2026",day,medium,clinicaltrials,NCT05617677,https://clinicaltrials.gov/study/NCT05617677
2026-10-20,BIIB,litifilimab,READOUT,"Oct 20, 2026",day,medium,clinicaltrials,NCT05531565,https://clinicaltrials.gov/study/NCT05531565
2026-10-26,NVS,inclisiran,READOUT,"Oct 26, 2026",day,medium,clinicaltrials,NCT05360446,https://clinicaltrials.gov/study/NCT05360446
2026-10-28,MRK,belzutifan,READOUT,"Oct 28, 2026",day,medium,clinicaltrials,NCT05239728,https://clinicaltrials.gov/study/NCT05239728
2026-10-29,MRK,belzutifan,READOUT,"Oct 29, 2026",day,medium,clinicaltrials,NCT04736706,https://clinicaltrials.gov/study/NCT04736706
2026-10-31,NUVL,alectinib,READOUT,"Oct 31, 2026",day,medium,clinicaltrials,NCT03178552,https://clinicaltrials.gov/study/NCT03178552
2026-10-31,VTRS,cenerimod,READOUT,"Oct 31, 2026",day,medium,clinicaltrials,NCT05648500,https://clinicaltrials.gov/study/NCT05648500
2026-10-31,IMMP,eftilagimod alpha,READOUT,"Oct 31, 2026",day,medium,clinicaltrials,NCT05747794,https://clinicaltrials.gov/study/NCT05747794
2026-10-31,NVS,inclisiran,READOUT,Oct 2026,month,medium,clinicaltrials,NCT03705234,https://clinicaltrials.gov/study/NCT03705234
2026-10-31,SBFM,minoxidil,READOUT,Oct 2026,month,medium,clinicaltrials,NCT05888922,https://clinicaltrials.gov/study/NCT05888922
2026-10-31,LLY,retatrutide,READOUT,Oct 2026,month,medium,clinicaltrials,NCT06297603,https://clinicaltrials.gov/study/NCT06297603
2026-10-31,OGN,tapinarof,READOUT,Oct 2026,month,medium,clinicaltrials,NCT05172726,https://clinicaltrials.gov/study/NCT05172726
2026-11-13,COGT,midazolam,READOUT,"Nov 13, 2026",day,medium,clinicaltrials,NCT05646862,https://clinicaltrials.gov/study/NCT05646862
2026-11-30,CGON,cretostimogene grenadenorepvec,READOUT,Nov 2026,month,medium,clinicaltrials,NCT06111235,https://clinicaltrials.gov/study/NCT06111235
2026-11-30,DAN,erwinia asparaginase,READOUT,"Nov 30, 2026",day,medium,clinicaltrials,NCT03020030,https://clinicaltrials.gov/study/NCT03020030
2026-11-30,NAMS,obicetrapib,READOUT,Nov 2026,month,medium,clinicaltrials,NCT05202509,https://clinicaltrials.gov/study/NCT05202509
2026-11-30,LLY,orforglipron,READOUT,Nov 2026,month,medium,clinicaltrials,NCT06649045,https://clinicaltrials.gov/study/NCT06649045
2026-11-30,DAN,pegaspargase,READOUT,"Nov 30, 2026",day,medium,clinicaltrials,NCT03020030,https://clinicaltrials.gov/study/NCT03020030
2026-11-30,LLY,tirzepatide,READOUT,Nov 2026,month,medium,clinicaltrials,NCT06914895,https://clinicaltrials.gov/study/NCT06914895
2026-12-01,VNDA,tradipitant,READOUT,"Dec 1, 2026",day,medium,clinicaltrials,NCT07446439,https://clinicaltrials.gov/study/NCT07446439
2026-12-02,MRK,enlicitide decanoate,READOUT,"Dec 2, 2026",day,medium,clinicaltrials,NCT07216482,https://clinicaltrials.gov/study/NCT07216482
2026-12-02,PFE,mevrometostat,READOUT,"Dec 2, 2026",day,medium,clinicaltrials,NCT06629779,https://clinicaltrials.gov/study/NCT06629779
2026-12-02,PFE,ritlecitinib higher,READOUT,"Dec 2, 2026",day,medium,clinicaltrials,NCT07029711,https://clinicaltrials.gov/study/NCT07029711
2026-12-02,PFE,ritlecitinib lower,READOUT,"Dec 2, 2026",day,medium,clinicaltrials,NCT07029711,https://clinicaltrials.gov/study/NCT07029711
2026-12-02,MRK,rosuvastatin calcium,READOUT,"Dec 2, 2026",day,medium,clinicaltrials,NCT07216482,https://clinicaltrials.gov/study/NCT07216482
2026-12-21,PFE,ritlecitinib,READOUT,"Dec 21, 2026",day,medium,clinicaltrials,NCT06873945,https://clinicaltrials.gov/study/NCT06873945
2026-12-26,INCY,povorcitinib,READOUT,"Dec 26, 2026",day,medium,clinicaltrials,NCT06212999,https://clinicaltrials.gov/study/NCT06212999
2026-12-30,INTS,pazopanib,READOUT,"Dec 30, 2026",day,medium,clinicaltrials,NCT03592472,https://clinicaltrials.gov/study/NCT03592472
2026-12-30,PFE,vepdegestrant,READOUT,"Dec 30, 2026",day,medium,clinicaltrials,NCT05909397,https://clinicaltrials.gov/study/NCT05909397
2026-12-31,PFE,axitinib,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT05059522,https://clinicaltrials.gov/study/NCT05059522
2026-12-31,AZN,darolutamide,READOUT,Dec 2026,month,medium,clinicaltrials,NCT03903835,https://clinicaltrials.gov/study/NCT03903835
2026-12-31,PFE,disitamab vedotin,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT05302284,https://clinicaltrials.gov/study/NCT05302284
2026-12-31,IONS,donidalorsen,READOUT,Dec 2026,month,medium,clinicaltrials,NCT05392114,https://clinicaltrials.gov/study/NCT05392114
2026-12-31,MRK,ibrutinib,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT01804686,https://clinicaltrials.gov/study/NCT01804686
2026-12-31,SMMT,ivonescimab,READOUT,Dec 2026,month,medium,clinicaltrials,NCT06767527,https://clinicaltrials.gov/study/NCT06767527
2026-12-31,PFE,lorlatanib,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT05059522,https://clinicaltrials.gov/study/NCT05059522
2026-12-31,ABBV,lutikizumab,READOUT,Dec 2026,month,medium,clinicaltrials,NCT06468228,https://clinicaltrials.gov/study/NCT06468228
2026-12-31,SNY,migalastat,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT04020055,https://clinicaltrials.gov/study/NCT04020055
2026-12-31,GNLX,olvimulogene nanivacirepvec,READOUT,Dec 2026,month,medium,clinicaltrials,NCT05281471,https://clinicaltrials.gov/study/NCT05281471
2026-12-31,UTHR,ralinepag,READOUT,Dec 2026,month,medium,clinicaltrials,NCT03683186,https://clinicaltrials.gov/study/NCT03683186
2026-12-31,DMAC,recombinant human tissue kallikrein,READOUT,Dec 2026,month,medium,clinicaltrials,NCT05065216,https://clinicaltrials.gov/study/NCT05065216
2026-12-31,LLY,retatrutide,READOUT,Dec 2026,month,medium,clinicaltrials,NCT06662383,https://clinicaltrials.gov/study/NCT06662383
2026-12-31,GILD,sacituzumab govitecan hziy,READOUT,Dec 2026,month,medium,clinicaltrials,NCT04639986,https://clinicaltrials.gov/study/NCT04639986
2026-12-31,PFE,talazoparib,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT05059522,https://clinicaltrials.gov/study/NCT05059522
2026-12-31,VOR,telitacicept,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT07249632,https://clinicaltrials.gov/study/NCT07249632
2026-12-31,PFE,utomilumab,READOUT,"Dec 31, 2026",day,medium,clinicaltrials,NCT05059522,https://clinicaltrials.gov/study/NCT05059522
2027-01-04,AZN,laroprovstat,READOUT,"Jan 4, 2027",day,medium,clinicaltrials,NCT07000136,https://clinicaltrials.gov/study/NCT07000136
2027-01-04,MRK,rescue medications,READOUT,"Jan 4, 2027",day,medium,clinicaltrials,NCT06356311,https://clinicaltrials.gov/study/NCT06356311
2027-01-04,MRK,supportive care measures,READOUT,"Jan 4, 2027",day,medium,clinicaltrials,NCT06356311,https://clinicaltrials.gov/study/NCT06356311
2027-01-10,BMY,mezigdomide,READOUT,"Jan 10, 2027",day,medium,clinicaltrials,NCT05519085,https://clinicaltrials.gov/study/NCT05519085
2027-01-11,AZN,laroprovstat,READOUT,"Jan 11, 2027",day,medium,clinicaltrials,NCT07000123,https://clinicaltrials.gov/study/NCT07000123
2027-01-13,SMMT,ivonescimab,READOUT,"Jan 13, 2027",day,medium,clinicaltrials,NCT06951503,https://clinicaltrials.gov/study/NCT06951503
2027-01-15,IDYA,darovasertib,READOUT,"Jan 15, 2027",day,medium,clinicaltrials,NCT05987332,https://clinicaltrials.gov/study/NCT05987332
2027-01-15,MLTX,sonelokimab,READOUT,"Jan 15, 2027",day,medium,clinicaltrials,NCT06641089,https://clinicaltrials.gov/study/NCT06641089
2027-01-21,AMGN,maridebart cafraglutide,READOUT,"Jan 21, 2027",day,medium,clinicaltrials,NCT06858839,https://clinicaltrials.gov/study/NCT06858839
2027-01-29,PFE,disitamab vedotin,READOUT,"Jan 29, 2027",day,medium,clinicaltrials,NCT05911295,https://clinicaltrials.gov/study/NCT05911295
2027-02-04,MLTX,sonelokimab,READOUT,"Feb 4, 2027",day,medium,clinicaltrials,NCT06641076,https://clinicaltrials.gov/study/NCT06641076
2027-02-11,NVS,inclisiran,READOUT,"Feb 11, 2027",day,medium,clinicaltrials,NCT07102628,https://clinicaltrials.gov/study/NCT07102628
2027-02-14,LLY,tirzepatide,READOUT,"Feb 14, 2027",day,medium,clinicaltrials,NCT07481747,https://clinicaltrials.gov/study/NCT07481747
2027-02-22,AZN,laroprovstat,READOUT,"Feb 22, 2027",day,medium,clinicaltrials,NCT06834932,https://clinicaltrials.gov/study/NCT06834932
2027-02-26,AZN,anifrolumab,READOUT,"Feb 26, 2027",day,medium,clinicaltrials,NCT05138133,https://clinicaltrials.gov/study/NCT05138133
2027-02-28,LLY,orforglipron,READOUT,Feb 2027,month,medium,clinicaltrials,NCT06672549,https://clinicaltrials.gov/study/NCT06672549
2027-02-28,GMAB,rina,READOUT,Feb 2027,month,medium,clinicaltrials,NCT06619236,https://clinicaltrials.gov/study/NCT06619236
2027-02-28,GILD,sacituzumab govitecan hziy,READOUT,Feb 2027,month,medium,clinicaltrials,NCT05382286,https://clinicaltrials.gov/study/NCT05382286
2027-03-01,NVO,cagrilintide,READOUT,"Mar 1, 2027",day,medium,clinicaltrials,NCT07011667,https://clinicaltrials.gov/study/NCT07011667
2027-03-13,RYTM,setmelanotide,READOUT,"Mar 13, 2027",day,medium,clinicaltrials,NCT06760546,https://clinicaltrials.gov/study/NCT06760546
2027-03-18,MRK,ibrutinib,READOUT,"Mar 18, 2027",day,medium,clinicaltrials,NCT04212013,https://clinicaltrials.gov/study/NCT04212013
2027-03-22,REGN,fianlimab,READOUT,"Mar 22, 2027",day,medium,clinicaltrials,NCT06246916,https://clinicaltrials.gov/study/NCT06246916
2027-03-24,NVS,ianalumab,READOUT,"Mar 24, 2027",day,medium,clinicaltrials,NCT05639114,https://clinicaltrials.gov/study/NCT05639114
2027-03-31,ARGX,efgartigimod,READOUT,Mar 2027,month,medium,clinicaltrials,NCT04833894,https://clinicaltrials.gov/study/NCT04833894
2027-03-31,IONS,olezarsen,READOUT,Mar 2027,month,medium,clinicaltrials,NCT05681351,https://clinicaltrials.gov/study/NCT05681351
2027-03-31,AAPG,olverembatinib,READOUT,"Mar 31, 2027",day,medium,clinicaltrials,NCT06640361,https://clinicaltrials.gov/study/NCT06640361
2027-03-31,MDGL,resmetirom,READOUT,Mar 2027,month,medium,clinicaltrials,NCT04951219,https://clinicaltrials.gov/study/NCT04951219
2027-03-31,AZN,rezvilutamide,READOUT,Mar 2027,month,medium,clinicaltrials,NCT07241416,https://clinicaltrials.gov/study/NCT07241416
2027-03-31,PFE,ritlecitinib,READOUT,"Mar 31, 2027",day,medium,clinicaltrials,NCT06163326,https://clinicaltrials.gov/study/NCT06163326
2027-03-31,NVS,tisagenlecleucel,READOUT,"Mar 31, 2027",day,medium,clinicaltrials,NCT04094311,https://clinicaltrials.gov/study/NCT04094311
2027-03-31,ONC,zanubrutinib,READOUT,Mar 2027,month,medium,clinicaltrials,NCT04002297,https://clinicaltrials.gov/study/NCT04002297
2027-04-12,NVS,ianalumab,READOUT,"Apr 12, 2027",day,medium,clinicaltrials,NCT05624749,https://clinicaltrials.gov/study/NCT05624749
2027-04-14,PFE,tofacitinib,READOUT,"Apr 14, 2027",day,medium,clinicaltrials,NCT04624230,https://clinicaltrials.gov/study/NCT04624230
2027-04-20,AZN,camizestrant,READOUT,"Apr 20, 2027",day,medium,clinicaltrials,NCT05774951,https://clinicaltrials.gov/study/NCT05774951
2027-04-25,LLY,lebrikizumab,READOUT,"Apr 25, 2027",day,medium,clinicaltrials,NCT06526182,https://clinicaltrials.gov/study/NCT06526182
2027-04-27,AMGN,maridebart cafraglutide,READOUT,"Apr 27, 2027",day,medium,clinicaltrials,NCT06987695,https://clinicaltrials.gov/study/NCT06987695
2027-04-30,MRK,ifinatamab deruxtecan,READOUT,"Apr 30, 2027",day,medium,clinicaltrials,NCT06203210,https://clinicaltrials.gov/study/NCT06203210
2027-04-30,NVS,iptacopan,READOUT,"Apr 30, 2027",day,medium,clinicaltrials,NCT06517758,https://clinicaltrials.gov/study/NCT06517758
2027-05-02,PFE,abrocitinib,READOUT,"May 2, 2027",day,medium,clinicaltrials,NCT06807268,https://clinicaltrials.gov/study/NCT06807268
2027-05-11,NVO,cagrilintide,READOUT,"May 11, 2027",day,medium,clinicaltrials,NCT07220642,https://clinicaltrials.gov/study/NCT07220642
2027-05-12,NVO,cagrilintide,READOUT,"May 12, 2027",day,medium,clinicaltrials,NCT07220759,https://clinicaltrials.gov/study/NCT07220759
2027-05-18,TAK,zasocitinib,READOUT,"May 18, 2027",day,medium,clinicaltrials,NCT06671483,https://clinicaltrials.gov/study/NCT06671483
2027-05-19,MRK,nemtabrutinib,READOUT,"May 19, 2027",day,medium,clinicaltrials,NCT05624554,https://clinicaltrials.gov/study/NCT05624554
2027-05-31,TEVA,deuruxolitinib,READOUT,May 2027,month,medium,clinicaltrials,NCT03898479,https://clinicaltrials.gov/study/NCT03898479
2027-05-31,LLY,orforglipron,READOUT,May 2027,month,medium,clinicaltrials,NCT07613307,https://clinicaltrials.gov/study/NCT07613307
2027-05-31,VOR,telitacicept,READOUT,May 2027,month,medium,clinicaltrials,NCT06456580,https://clinicaltrials.gov/study/NCT06456580
2027-06-02,NVS,pelabresib,READOUT,"Jun 2, 2027",day,medium,clinicaltrials,NCT06401356,https://clinicaltrials.gov/study/NCT06401356
2027-06-07,MRK,belzutifan,READOUT,"Jun 7, 2027",day,medium,clinicaltrials,NCT05899049,https://clinicaltrials.gov/study/NCT05899049
2027-06-18,REGN,mibavademab,READOUT,"Jun 18, 2027",day,medium,clinicaltrials,NCT07220772,https://clinicaltrials.gov/study/NCT07220772
2027-06-30,PFE,binimetinib,READOUT,Jun 2027,month,medium,clinicaltrials,NCT05615818,https://clinicaltrials.gov/study/NCT05615818
2027-06-30,AZN,datopotamab deruxtecan,READOUT,"Jun 30, 2027",day,medium,clinicaltrials,NCT06564844,https://clinicaltrials.gov/study/NCT06564844
2027-06-30,PHVS,deucrictibant,READOUT,Jun 2027,month,medium,clinicaltrials,NCT05396105,https://clinicaltrials.gov/study/NCT05396105
2027-06-30,IMMP,eftilagimod alfa,READOUT,Jun 2027,month,medium,clinicaltrials,NCT06726265,https://clinicaltrials.gov/study/NCT06726265
2027-06-30,PFE,encorafenib,READOUT,Jun 2027,month,medium,clinicaltrials,NCT05615818,https://clinicaltrials.gov/study/NCT05615818
2027-06-30,GMAB,epcoritamab,READOUT,Jun 2027,month,medium,clinicaltrials,NCT05578976,https://clinicaltrials.gov/study/NCT05578976
2027-06-30,IMNN,niraparib,READOUT,Jun 2027,month,medium,clinicaltrials,NCT03651206,https://clinicaltrials.gov/study/NCT03651206
2027-06-30,AZN,rilvegostomig,READOUT,"Jun 30, 2027",day,medium,clinicaltrials,NCT06564844,https://clinicaltrials.gov/study/NCT06564844
2027-06-30,GILD,sacituzumab govitecan hziy,READOUT,Jun 2027,month,medium,clinicaltrials,NCT05633654,https://clinicaltrials.gov/study/NCT05633654
2027-06-30,AMGN,sotorasib,READOUT,"Jun 30, 2027",day,medium,clinicaltrials,NCT05920356,https://clinicaltrials.gov/study/NCT05920356
2027-06-30,JAZZ,zanidatamab,READOUT,Jun 2027,month,medium,clinicaltrials,NCT05615818,https://clinicaltrials.gov/study/NCT05615818
2027-07-02,NVO,ziltivekimab,READOUT,"Jul 2, 2027",day,medium,clinicaltrials,NCT05636176,https://clinicaltrials.gov/study/NCT05636176
2027-07-05,AMGN,tarlatamab,READOUT,"Jul 5, 2027",day,medium,clinicaltrials,NCT06211036,https://clinicaltrials.gov/study/NCT06211036
2027-07-28,AZN,datopotamab deruxtecan,READOUT,"Jul 28, 2027",day,medium,clinicaltrials,NCT06103864,https://clinicaltrials.gov/study/NCT06103864
2027-07-30,GMAB,acasunlimab,READOUT,"Jul 30, 2027",day,medium,clinicaltrials,NCT06635824,https://clinicaltrials.gov/study/NCT06635824
2027-07-30,AZN,darolutamide,READOUT,"Jul 30, 2027",day,medium,clinicaltrials,NCT05794906,https://clinicaltrials.gov/study/NCT05794906
2027-07-30,PFE,ritlecitinib,READOUT,"Jul 30, 2027",day,medium,clinicaltrials,NCT06072183,https://clinicaltrials.gov/study/NCT06072183
2027-07-31,AZN,dapagliflozin,READOUT,Jul 2027,month,medium,clinicaltrials,NCT05374291,https://clinicaltrials.gov/study/NCT05374291
2027-07-31,LLY,retatrutide,READOUT,Jul 2027,month,medium,clinicaltrials,NCT07232719,https://clinicaltrials.gov/study/NCT07232719
2027-08-04,PFE,elranatamab,READOUT,"Aug 4, 2027",day,medium,clinicaltrials,NCT05317416,https://clinicaltrials.gov/study/NCT05317416
2027-08-07,AZN,tezepelumab,READOUT,"Aug 7, 2027",day,medium,clinicaltrials,NCT07363642,https://clinicaltrials.gov/study/NCT07363642
2027-08-09,BMY,golcadomide,READOUT,"Aug 9, 2027",day,medium,clinicaltrials,NCT06356129,https://clinicaltrials.gov/study/NCT06356129
2027-08-20,ARWR,zodasiran,READOUT,"Aug 20, 2027",day,medium,clinicaltrials,NCT07037771,https://clinicaltrials.gov/study/NCT07037771
2027-08-27,AZN,ravulizumab,READOUT,"Aug 27, 2027",day,medium,clinicaltrials,NCT07596784,https://clinicaltrials.gov/study/NCT07596784
2027-08-31,AAPG,lisaftoclax,READOUT,Aug 2027,month,medium,clinicaltrials,NCT06319456,https://clinicaltrials.gov/study/NCT06319456
2027-08-31,LLY,orforglipron,READOUT,Aug 2027,month,medium,clinicaltrials,NCT06972459,https://clinicaltrials.gov/study/NCT06972459
2027-08-31,CRNX,paltusotine,READOUT,Aug 2027,month,medium,clinicaltrials,NCT07087054,https://clinicaltrials.gov/study/NCT07087054
2027-08-31,ABBV,telisotuzumab adizutecan,READOUT,Aug 2027,month,medium,clinicaltrials,NCT06614192,https://clinicaltrials.gov/study/NCT06614192
2027-08-31,MRK,tocilizumab,READOUT,"Aug 31, 2027",day,medium,clinicaltrials,NCT06084936,https://clinicaltrials.gov/study/NCT06084936
2027-09-01,NVO,cagrilintide,READOUT,"Sep 1, 2027",day,medium,clinicaltrials,NCT05669755,https://clinicaltrials.gov/study/NCT05669755